Skip to content
    MCHP
    Earnings call· Mar 2025(Q4 FY25)

    MICROCHIP TECHNOLOGY Q4 FY25 earnings call MCHP

    May 8, 2025 Source

    Executive summary

    Microchip Technology Q4 FY25 — Inventory Bottom and Recovery Inflection

    Microchip Technology reported Q4 FY25 results indicating an inflection point, with management calling the quarter a revenue bottom. The company is executing a 9-point recovery plan, focusing on inventory reduction, operational efficiency, and strengthening customer relationships. Bookings are showing significant improvement, and the company anticipates substantial financial performance gains in the upcoming fiscal year, driven by inventory normalization and operational leverage.

    Highlights

    5
    • Net sales of $970.5 million exceeded the midpoint of guidance by $10.5 million.

    • Book-to-bill ratio in the March quarter was a very healthy 1.07, after nearly 3 years below 1.0.

    • Inventory reduced by 15 days sequentially to 251 days, marking the first meaningful reduction in 3 years.

    • 78% of previously stressed customer relationships (12% of total) were restored to approved or preferred status.

    • Net debt decreased by $1.31 billion, and total debt decreased by $1.125 billion, reaffirming investment-grade rating.

    Concerns

    5
    • Net sales were down 5.4% sequentially and 26.8% year-over-year due to inventory correction.

    • Non-GAAP gross margins were 52%, impacted by $54.2 million in capacity underutilization charges.

    • Non-GAAP operating income was 14% of sales, reflecting continued cost pressures.

    • GAAP net loss attributable to common shareholders was $156.8 million, or $0.29 per share.

    • Adjusted free cash flow is currently less than the dividend, though expected to improve with inventory liberation.

    Guidance & targets

    9
    CategoryTargetConfidence
    Net sales
    $1.045 billion +/- $25 million
    high materiality
    High
    Non-GAAP gross margin
    52.2% to 54.2% of sales
    medium materiality
    High
    Non-GAAP operating expenses
    33.4% and 34.8% of sales
    medium materiality
    High
    Non-GAAP operating profit
    17.4% and 20.8% of sales
    high materiality
    High
    Non-GAAP diluted earnings per share
    $0.18 and $0.26
    high materiality
    High
    Inventory reduction
    over $350 million
    high materiality
    High
    Capital expenditures
    at or below $100 million
    medium materiality
    High
    Non-GAAP tax rate
    about 12%
    low materiality
    High
    Long-term Non-GAAP gross margin
    65%
    high materiality
    High

    Segment performance

    7
    SegmentRevenueYoYQoQMargin
    Microcontroller and Analog business units
    Revenue was down sequentially.
    down sequentially
    FPGA
    Revenue was about flat sequentially.
    about flat
    Other businesses
    Mainly driven by technology licensing.
    up sequentially
    Americas
    Business was seasonally down sequentially.
    seasonally down sequentially
    Asia
    Business was seasonally down sequentially.
    seasonally down sequentially
    Europe
    Business was seasonally up.
    seasonally up
    Aerospace and Defense
    Became the second largest market after industrial in FY25, growing due to strong defense budgets and NATO spending.
    Percentage of business: 18% in FY25Percentage of business: 11% in prior year

    Operational metrics

    36
    Non-GAAP gross margin
    52%
    Q4 FY25

    Includes capacity underutilization charges.

    Non-GAAP operating expenses
    38%
    Q4 FY25

    As a percentage of sales.

    Non-GAAP operating income
    14%
    Q4 FY25

    As a percentage of sales.

    Non-GAAP net income
    $61.4 million
    Q4 FY25

    Reported for the March quarter.

    Non-GAAP EPS
    $0.11$0.01 above midpoint of guidance
    Q4 FY25

    Exceeded midpoint of guidance.

    GAAP gross margins
    51.6%
    Q4 FY25

    Reported for the March quarter.

    GAAP total operating expenses
    $601.4 million
    Q4 FY25

    Includes various charges.

    GAAP net loss attributable to common shareholders
    $156.8 million
    Q4 FY25

    Reported for the March quarter.

    GAAP EPS
    $0.29
    Q4 FY25

    Reported for the March quarter.

    FY25 Net Sales
    $4.402 billiondown 42.3% from FY24
    FY25

    Full fiscal year 2025 net sales.

    FY25 Non-GAAP gross margins
    57%
    FY25

    Full fiscal year 2025 non-GAAP gross margins.

    FY25 Non-GAAP operating expenses
    32.5%
    FY25

    Full fiscal year 2025 non-GAAP operating expenses as a percentage of sales.

    FY25 Non-GAAP operating income
    24.5%
    FY25

    Full fiscal year 2025 non-GAAP operating income as a percentage of sales.

    FY25 Non-GAAP net income
    $708.8 million
    FY25

    Full fiscal year 2025 non-GAAP net income.

    FY25 Non-GAAP EPS
    $1.31
    FY25

    Full fiscal year 2025 non-GAAP EPS.

    FY25 GAAP gross margins
    56.1%
    FY25

    Full fiscal year 2025 GAAP gross margins.

    FY25 GAAP operating expenses
    49.3%
    FY25

    Full fiscal year 2025 GAAP operating expenses as a percentage of sales.

    FY25 GAAP operating income
    6.7%
    FY25

    Full fiscal year 2025 GAAP operating income as a percentage of sales.

    FY25 GAAP net loss attributable to common shareholders
    $2.7 million
    FY25

    Full fiscal year 2025 GAAP net loss.

    Non-GAAP cash tax rate
    13.6%
    Q4 FY25

    Reported for the March quarter.

    Non-GAAP cash tax rate
    14.2%
    FY25

    Reported for fiscal year 2025.

    Cash and investments balance
    $771.7 million
    Q4 FY25

    Consolidated cash and total investment position as of March 31, 2025.

    Total debt decrease
    $1.125 billion
    Q4 FY25

    Decrease in total debt during the March quarter.

    Net debt decrease
    $1.31 billion
    Q4 FY25

    Decrease in net debt during the March quarter.

    Adjusted EBITDA
    $200.4 million
    Q4 FY25

    Reported for the March quarter.

    Adjusted EBITDA margin
    20.6%
    Q4 FY25

    As a percentage of net sales for the March quarter.

    Trailing 12-month adjusted EBITDA
    $1.337 billion
    TTM Q4 FY25

    Trailing 12-month adjusted EBITDA as of March 31, 2025.

    Net debt to adjusted EBITDA
    3.66x
    Q4 FY25

    As of March 31, 2025.

    Capital expenditures
    $14.2 million
    Q4 FY25

    Reported for the March quarter.

    Capital expenditures
    $126 million
    FY25

    Reported for fiscal year 2025.

    Depreciation expense
    $41.2 million
    Q4 FY25

    Reported for the March quarter.

    Incremental operating profit leverage
    85%
    Q1 FY26

    Percentage of sequential net sales increase expected to flow to non-GAAP operating profit at the midpoint of Q1 FY26 guidance.

    Customer relationships restored
    78%
    Past 130+ days

    Percentage of customers whose relationships had deteriorated through the COVID cycle that have been restored to approved or preferred status.

    Employee layoff
    10%
    Q4 FY25

    Global layoff to bring down operating expenses.

    AI as percentage of sales
    just over 6%up from 4% last year
    Current

    Percentage of sales attributed to AI-related products.

    Distributor sell-through vs sell-in
    $103 million
    Q4 FY25

    Distribution sell-through was higher than sell-in, indicating inventory reduction at distributors.

    Industry KPIs

    8
    MetricValueDetails
    Backlog order bookhigher
    Book to bill ratio1.07
    Ai data center revenuejust over 6%% of sales
    Fab capacity utilizationlow rate
    Bookings net order intakesignificantly higher
    Design wins socket pipelinelarge number
    Inventory channel inventory251 daysdays
    End market segment revenue mixAerospace and Defense: 18%%

    Orderbook & backlog

    4
    Book-to-bill ratio1.07Q4 FY25

    first time above 1.0 in nearly 3 years

    June quarter starting backloghigher than March quarter starting backlogQ1 FY26 start
    April bookingshigher than any month in March quarterApril 2025
    September quarter backloghigher than June quarter backlogMay 8, 2025

    Compared to June quarter backlog at the same point in time (February 8, 2025).

    Product announcements

    6
    ProductTypeDetails
    Switchtec PCIe switchesupdate
    ARM-based microprocessorsupdate
    32-bit microcontrollersupdate
    MPLAB AI coding assistantlaunch
    PIC64 product lineupdate
    10BASE-T1S solutionsupdate

    Deals & partnerships

    1
    Mandatory convertible preferred stock offeringOffering of preferred stock to reduce debt and preserve investment-grade rating.$1.485 billion3-year term

    Completed a $1.485 billion mandatory convertible preferred stock offering with a 3-year term and purchased a cap call with an initial cap price of $71.40 per share. This was done to reduce debt and preserve the investment-grade rating.

    Risks & headwinds

    6
    Inventory correctionOngoing, expected to continue through FY26

    Inventory at 251 days (down from 266 days), target 130-150 days. Distributor inventory at 33 days (down from 37 days).

    Mitigation: Reduced production for all of the June quarter, targeting over $350 million inventory reduction in FY26. Aggressive actions to reduce inventory and improve utilization.

    Capacity underutilization chargesQ4 FY25, expected to continue in Q1 FY26

    $54.2 million in Q4 FY25

    Mitigation: Running factories at a low rate to reduce inventory. Charges expected to decrease as revenue increases and inventory drops.

    Inventory reserve chargesQ4 FY25, Q1 FY26, expected to drop dramatically thereafter

    Still high in Q4 FY25, expected to be large in Q1 FY26

    Mitigation: Aggressive inventory reduction will lead to a dramatic drop in reserve charges as products subject to review decrease.

    Tariff impact on global economyOngoing

    Unquantified indirect impact on global GDP

    Mitigation: Modeled hypothetical revenue haircuts; current production rates are low enough that inventory would still decline, avoiding additional drastic actions. Direct tariff impact on Microchip is minimal due to production shifts.

    China-for-China strategy effectivenessOngoing

    Impact on U.S.-made products due to changed definition of 'Made in China'

    Mitigation: Re-evaluating strategy, giving feedback to government on incentives to move production out of U.S. Exploring transferring mask sets to Taiwan for dual-sourced products.

    Adjusted free cash flow below dividendCurrent, expected to improve

    Adjusted free cash flow currently less than dividend

    Mitigation: No dividend cut planned. Expect adjusted free cash flow to exceed dividend as cash is liberated from inventory and capital expenditures remain low.

    What to watch in Q1 FY26

    5

    Inventory days

    Q1 FY26
    Current251 days
    Target215-225 days

    Why it matters

    Significant reduction in inventory is key to liberating cash and improving gross margins by reducing write-offs.

    The inventory at the end of June is expected to be between 215 and 225 days.

    Q&A highlights

    6

    What demand signals support the bottom call, and is there any pull-in from tariffs? How are key end markets performing?

    Demand signals started in early January with significant booking increases, unrelated to tariffs. Tariffs have no direct impact on semiconductors. Aerospace and defense is a strong segment (18% of FY25 sales), and a broad-based recovery is seen across industrial, automotive, and consumer markets, driven by inventory depletion and new designs.

    The demand signals we are seeing really began in -- starting early January. Our January, February, March, each of those 3 months bookings were significantly higher than December quarter bookings, and we have shown them on a slide on the March 3 conference call that we had, and that was really before any of the tariffs talk appeared.

    asked by Harsh Kumar · answered by Steve Sanghi

    3 min read6 chapters

    Detailed Narrative

    01

    9-Point Recovery Plan Progress

    CEO Steve Sanghi provided an update on the 9-point recovery plan initiated on March 3, 2025. Key actions completed include resizing the manufacturing footprint (Tempe Fab 2 closed, actions in Fab 4 and Fab 5 complete, back-end Philippines facilities complete), reducing inventory (first meaningful reduction in 3 years), reviewing megatrends (replacing 5G with AI, ADAS with network and connectivity), conducting business unit deep dives, and strengthening customer relationships (78% of stressed customers restored). A global layoff of approximately 10% of employees was executed to improve operating expenses, and discussions with the CHIPS office were reinitiated.

    02

    Inventory Correction and Production Strategy

    The company achieved its first meaningful inventory reduction in three years, with days of inventory decreasing from 266 to 251 days. Management expects further substantial reductions in the June quarter, targeting 215-225 days, and a total reduction of over $350 million in FY26. Production will remain reduced in the June quarter to facilitate destocking. While the long-term target is 130-150 days, production will need to ramp up before reaching this level to avoid a steep capacity hill to climb later, with an inflection point expected later in FY26.

    03

    Revenue Inflection and Demand Signals

    Management declared the March quarter as a revenue bottom, citing strong demand signals. Bookings were significantly up in the March quarter, with a book-to-bill ratio of 1.07, the first above 1.0 in nearly three years. April bookings were higher than any month in the March quarter. Distributor sell-through is increasing, and direct customer shipments are rising due to inventory depletion. This 'trifecta effect' of distributor inventory correction, sell-in catching up to sell-through, and direct customer inventory correction is expected to drive sales growth in FY26.

    04

    China Strategy and Tariff Impact

    Microchip is re-evaluating its China-for-China strategy due to changes in the definition of 'Made in China' from assembly location to diffusion location. The previous strategy of selling Microchip die for local assembly and branding is less effective for U.S.-made products. The company is giving feedback to the U.S. government that current rules incentivize moving production out of the U.S. Direct tariff impact🌐 is minimal as less than 4% of parts are made in China and those don't typically go to the U.S. The company has modeled hypothetical revenue haircuts and believes its reduced production rates can absorb such impacts without further drastic actions.

    05

    Product Innovation and AI Focus

    Microchip continues to invest in next-generation technologies, including Switchtec PCIe switches for automotive and embedded computing, ARM-based microprocessors for HMI, and 32-bit microcontrollers with high-performance analog peripherals. The MPLAB AI coding assistant is helping customers accelerate design cycles, reducing embedded software development time by up to 40%. The company has also created an AIML product group to coordinate AI-related efforts across business units. AI-related sales now represent just over 6% of total sales, up from 4% last year.

    06

    Capital Allocation and Dividend Commitment

    The company is committed to returning 100% of adjusted free cash flow to investors via dividends. Despite adjusted free cash flow currently being less than the dividend due to depressed sales, management has no plans to cut the dividend. A $1.485 billion mandatory convertible preferred stock offering in the March quarter reduced total debt by $1.125 billion and net debt by $1.31 billion, reaffirming the company's investment-grade debt rating. The company expects adjusted free cash flow to exceed dividends as inventory liberates cash and capital expenditures remain low.

    AI-generated summary of the company’s earnings call. Not investment advice.